Low energy internal atrial cardioversion in atrial fibrillation lasting more than a year

PACE - Pacing and Clinical Electrophysiology

Volumn 22, Issue 1 II, 1999, Pages 243-246

  Boriani, Giuseppe ^a   Biffi, Mauro ^b   Pergolini, Francesco ^b   Zannoli, Romano ^b   Branzi, Angelo ^b   Magnani, Bruno ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE

Author keywords

Antiarrhythmic drugs; Atrial fibrillation; Cardioversion; Defibrillation

Indexed keywords

AMIODARONE; ANESTHETIC AGENT; DIGOXIN; FLECAINIDE; SEDATIVE AGENT; SOTALOL;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; ENERGY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; RECURRENT DISEASE; SINUS RHYTHM;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CHRONIC DISEASE; ELECTRIC COUNTERSHOCK; ELECTRIC IMPEDANCE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HEART CATHETERIZATION; HEART RATE; HUMANS; MALE; MIDDLE AGED; PULMONARY ARTERY; RECURRENCE; TREATMENT OUTCOME;

EID: 0032924353     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1999.tb00341.x     Document Type: Article

References (17)

1. Van Gelder I, Crijns HJGM. Cardioversion of atrial fibrillation and subsequent maintenance of sinus rhythm. PACE 1998; 20:2675-2683.
2. Levy S, Ricard P, Lau CP, et al. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol 1997; 29:750-755.
3. Sopher SM, Murgatroyd FD, Slade AKD, et al. Low energy internal cardioversion of atrial fibrillation resistant to transthoracic shocks. Heart 1996; 75:635-638.
4. Boriani G, Biffi M, Bronzetti G, et al. Efficacy and tolerability in fully conscious patients of transvenous low energy internal atrial cardioversion for atrial fibrillation. Am J Cardiol 1998; 81: 241-244.
5. Crijns HJGM, Van Gelder I, Van Gilst WH, et al. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or flutter. Am J Cardiol 1991; 68:335-341.
6. De Silva RA, Graboys TB, Podrid PJ, et al. Cardioversion and defibrillation. Am Heart J 1980; 100:881-895.
7. Ewy GA Cardioversion. In GA Ewy, R Bressler (eds.): Cardiovascular Drugs and the Management of Heart Disease. New York, Raven Press, 1982, pp. 427-440.
8. Zipes DP. Management of cardiac arrhythmias: Pharmacological, electrical and surgical techniques. In E Braunwald (ed.): Heart Disease. Philadelphia, WB Saunders, 1997, pp. 593-639.
9. Morris JJ, Peter RH, McIntosh HD. Electrical cardioversion of atrial fibrillation. Ann Intern Med 1966; 65:216-231.
10. Van Gelder IC, Crijns HJ, Van Gilst WH, et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation or flutter. Am J Cardiol 1991; 68:41-46.
11. O'Toole L, Williams A, Shaw TDR, et al. Hypertension strongly predicts early relapses after effective cardioversion of atrial fibrillation. (abstract) J Am Coll Cardiol 1998; 31(Suppl A):195A.
12. Wijffels MCEF, Kirchof CJHJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995; 92:1954-1968.
13. Daoud EG, Bogun F, Harvey M, et al. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation 1996; 94:1600-1606.
14. Szekely P, Wynne NA, Pearson DT, et al. Direct current shock and antidysrhythmic drugs . Br Heart J 1970; 32:209-218.
15. Sagristà-Sauleda J, Permanyer-Miralda G, Soler-Soler J. Electrical cardioversion after amiodarone administration. Am Heart J 1992; 123:1536-1542.
16. Bianconi L, Mennani M, Lukic V, et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: A placebo controlled study. J Am Coll Cardiol 1996; 28:700-706.
17. Boriani G, Biffi M, Capucci A, et al. Atrial fibrillation: Favorable effects of flecainide in transvenous low energy internal atrial cardioversion (abstract). J Am Coll Cardiol 1998; 31(Suppl A):196A.